Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pauli V. Luoma. (2013) Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases. Annals of Medicine 45:2, pages 194-202.
Read now
Read now
Pauli V. Luoma. (2007) Cytochrome P450 — physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Annals of Medicine 39:5, pages 359-370.
Read now
Read now
Articles from other publishers (21)
Jussi Mäkinen, Sirpa Rainesalo, Jani Raitanen, Jukka Saarinen, Satu Sandell & Jukka Peltola. (2018) Discontinuation of carbamazepine due to concerns of long‐term consequences of enzyme induction. Epilepsia Open 3:3, pages 340-347.
Crossref
Crossref
M. I. Lossius, K. O. Nakken, P. Mowinckel, E. Taubøll & L. Gjerstad. (2016) Favorable change of lipid profile after carbamazepine withdrawal. Acta Neurologica Scandinavica 134:3, pages 219-223.
Crossref
Crossref
Martin J. Brodie, Scott Mintzer, Alison M. Pack, Barry E. Gidal, Charles J. Vecht & Dieter Schmidt. (2012) Enzyme induction with antiepileptic drugs: Cause for concern?. Epilepsia 54:1, pages 11-27.
Crossref
Crossref
Torbjörn Lindström, Stergios Kechagias, Martin Carlsson & Fredrik H. Nystrom. (2012) Transient Increase in HDL‐Cholesterol During Weight Gain by Hyperalimentation in Healthy Subjects. Obesity 19:4, pages 812-817.
Crossref
Crossref
Scott Mintzer & Richard T. Mattson. (2009) Should enzyme‐inducing antiepileptic drugs be considered first‐line agents?. Epilepsia 50:s8, pages 42-50.
Crossref
Crossref
Scott Mintzer, Christopher T. Skidmore, Caitlin J. Abidin, Megan C. Morales, Inna Chervoneva, David M. Capuzzi & Michael R. Sperling. (2009) Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein. Annals of Neurology 65:4, pages 448-456.
Crossref
Crossref
P. -V. Lunoma. (2009) Cytochrome P450 et activation génétique — de la pharmacologie à l’élimination du cholestérol et à la régression de l’athéroscléroseCytochrome P450 and gene activation — from pharmacology to cholesterol elimination and regression of atherosclerosis. Bio tribune magazine 30:1, pages 15-24.
Crossref
Crossref
Pauli V. Luoma. (2008) Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis. European Journal of Clinical Pharmacology 64:9, pages 841-850.
Crossref
Crossref
Manuel Castro-GagoMaría Inés Novo-Rodríguez, Manuel Oscar Blanco-Barca, Adela Urisarri-Ruíz de Cortázar, Javier Rodríguez-García, Santiago Rodríguez-Segade & Jesús Eirís-Puñal. (2016) Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital. Journal of Child Neurology 21:1, pages 48-53.
Crossref
Crossref
María J. Tutor‐Crespo, Jesús Hermida & J. Carlos Tutor. (2013) Possible Induction of Cholinesterase in Epileptic Patients Treated With Anticonvulsant Drugs: Relationship With Lipoprotein Levels. The Journal of Clinical Pharmacology 44:9, pages 974-980.
Crossref
Crossref
F. Müjgan Aynaci, Fazil Orhan, Asim Orem, Sermet Yildirmis & Yusuf Gedik. (2016) Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood. Journal of Child Neurology 16:5, pages 367-369.
Crossref
Crossref
J Eirı́s, MaI Novo-Rodrı́guez, M Del Rı́o, P Meseguer, M.C Del Rı́o & M Castro-Gago. (2000) The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Research 41:1, pages 1-7.
Crossref
Crossref
Chris Goerdt, Mary Keith & Hanna Bloomfield Rubins. (2013) Effects of Phenytoin on Plasma High‐Density Lipoprotein Cholesterol Levels in Men with Low Levels of High‐Density Lipoprotein Cholesterol. The Journal of Clinical Pharmacology 35:8, pages 767-775.
Crossref
Crossref
Jouko I. T. Isojärvi, Arto J. Pakarinen, Arja Rautio, Olavi Pelkonen & Vilho V. Myllylä. (2005) Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine. Epilepsia 35:6, pages 1217-1220.
Crossref
Crossref
James M. McKenney, Kathleen S. Petrizzi, Geneva C. Briggs & Jackson T. WrightJr.Jr.. (2012) The Effect of Low‐Dose Phenytoin on High‐Density Lipoprotein Cholesterol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 12:3, pages 183-188.
Crossref
Crossref
P. V. Luoma, A. Rautio, J. Steng�rd, E. A. Sotaniemi & J. Marniemi. (1990) High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects. European Journal of Clinical Pharmacology 38:6, pages 625-627.
Crossref
Crossref
René Tempelhoff, Paul A. Modica & Edward L. Spitznagel. (1990) Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy. Canadian Journal of Anaesthesia 37:3, pages 327-332.
Crossref
Crossref
R. F. Heller, D. A. Henry & P. J. Brent. (2007) ENZYME INDUCTION BY EATING CHARCOAL‐GRILLED STEAK WITH NO EFFECT ON BLOOD LIPIDS. Clinical and Experimental Pharmacology and Physiology 16:10, pages 783-788.
Crossref
Crossref
P. V. Luoma. (2009) Mlicrosomal Enzyme Induction, Lipoproteins and Atherosclerosis. Pharmacology & Toxicology 62:5, pages 243-249.
Crossref
Crossref
J. Bonneterre, N. Ghalim, M. Nguyen, P. Puchois, A. Demaille, C. Demarquilly & JC. Fruchart. (1987) Variations in lipoproteins during aminoglutethimide therapy. Breast Cancer Research and Treatment 10:2, pages 197-200.
Crossref
Crossref
P. V. Luoma, H. Korpela, E. A. Sotaniemi & J. Kumpulainen. (1985) Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity. Biological Trace Element Research 8:2, pages 113-121.
Crossref
Crossref